Newron Pharmaceuticals has signed a strategic collaboration and licence agreement with Zambon Company for Safinamide in the EU and US. As per the agreement, Zambon will initially invest €20m into Newron, covering the completion ...
Tags: collaboration, pharmaceutical product, clinical development, Safinamide